View in EDS

Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis.

Saved in:
Bibliographic Details
Title: Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis.
Authors: Rangani F; Department of Clinical Neuroscience, Karolinska Institutet, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical sciences, Mashhad, Iran., Nahayati MA; Department of Neurology and Rehabilitation, Waddell Center for Multiple Sclerosis, Cincinnati University, OH, USA., Pahlevan Kakhki M; Department of Clinical Neuroscience, Karolinska Institutet, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden. Electronic address: Majid.Pahlevan.kakhki@ki.se., Aghaee-Bakhtiari SH; Bioinformatics Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.. Electronic address: aghaeibh@mums.ac.ir.
Source: Journal of the neurological sciences [J Neurol Sci] 2026 Jan 15; Vol. 480, pp. 125693. Date of Electronic Publication: 2025 Dec 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41389414
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rangani+F%22">Rangani F</searchLink>; Department of Clinical Neuroscience, Karolinska Institutet, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Medical Biotechnology and Nanotechnology, Mashhad University of Medical sciences, Mashhad, Iran.<br /><searchLink fieldCode="AU" term="%22Nahayati+MA%22">Nahayati MA</searchLink>; Department of Neurology and Rehabilitation, Waddell Center for Multiple Sclerosis, Cincinnati University, OH, USA.<br /><searchLink fieldCode="AU" term="%22Pahlevan+Kakhki+M%22">Pahlevan Kakhki M</searchLink>; Department of Clinical Neuroscience, Karolinska Institutet, and Center for Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden. Electronic address: Majid.Pahlevan.kakhki@ki.se.<br /><searchLink fieldCode="AU" term="%22Aghaee-Bakhtiari+SH%22">Aghaee-Bakhtiari SH</searchLink>; Bioinformatics Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran.. Electronic address: aghaeibh@mums.ac.ir.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220375403%22">Journal of the neurological sciences</searchLink> [J Neurol Sci] 2026 Jan 15; Vol. 480, pp. 125693. <i>Date of Electronic Publication: </i>2025 Dec 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0375403 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1878-5883 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220022510X%22">0022510X </searchLink><i>NLM ISO Abbreviation: </i>J Neurol Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41389414
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jns.2025.125693
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 125693
    Titles:
      – TitleFull: Ocrelizumab modulates the IL-2 signaling pathway and associated lncRNAs in multiple sclerosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rangani F
      – PersonEntity:
          Name:
            NameFull: Nahayati MA
      – PersonEntity:
          Name:
            NameFull: Pahlevan Kakhki M
      – PersonEntity:
          Name:
            NameFull: Aghaee-Bakhtiari SH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 01
              Text: 2026 Jan 15
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1878-5883
          Numbering:
            – Type: volume
              Value: 480
          Titles:
            – TitleFull: Journal of the neurological sciences
              Type: main
ResultId 1